Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) (2011 - 2026)

Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.96 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 34.61 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.64 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3.76 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 554.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 107.22 Mn
10 Gyre Therapeutics 708.31 Mn 685.47 Mn 26.90 Mn 27.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 27.28 Mn
Jun 30, 2026 27.28 Mn
Mar 31, 2026 23.57 Mn
Mar 31, 2026 23.57 Mn
Dec 31, 2025 23.60 Mn
Dec 31, 2025 23.60 Mn
Sep 30, 2025 23.61 Mn
Sep 30, 2025 23.61 Mn
Jun 30, 2025 23.40 Mn
Jun 30, 2025 23.40 Mn
Mar 31, 2025 23.52 Mn
Mar 31, 2025 23.52 Mn
Dec 31, 2024 23.88 Mn
Dec 31, 2024 23.88 Mn
Sep 30, 2024 24.44 Mn
Sep 30, 2024 24.44 Mn
Jun 30, 2024 23.67 Mn
Jun 30, 2024 23.67 Mn
Mar 31, 2024 23.56 Mn
Mar 31, 2024 23.56 Mn